Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126600351 | 12660035 | 1 | I | 2015 | 20150813 | 20160817 | 20160817 | PER | US-UCBSA-2015026531 | UCB | 0.00 | F | Y | 90.00000 | KG | 20160817 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126600351 | 12660035 | 1 | PS | ISOSORBIDE MONONITRATE. | ISOSORBIDE MONONITRATE | 1 | UNK | U | 20215 | ||||||||||
| 126600351 | 12660035 | 2 | C | ASPIRIN. | ASPIRIN | 1 | 81 MG COATED | U | U | 0 | |||||||||
| 126600351 | 12660035 | 3 | C | DILTIAZEM. | DILTIAZEM | 1 | 180 MG | U | U | 0 | |||||||||
| 126600351 | 12660035 | 4 | C | LOSARTAN. | LOSARTAN | 1 | 100/25 MG | U | U | 0 | |||||||||
| 126600351 | 12660035 | 5 | C | VITAMIN D | CHOLECALCIFEROL | 1 | 56000 UNITS A WEEK | U | U | 0 | |||||||||
| 126600351 | 12660035 | 6 | C | ALPRAZOLAM. | ALPRAZOLAM | 1 | 1 MG, 2X/DAY (BID) | U | U | 0 | 1 | MG | BID | ||||||
| 126600351 | 12660035 | 7 | C | OMEPRAZOLE. | OMEPRAZOLE | 1 | STOMACH PILL 40 MG ONE OR TWO A DAY | U | U | 0 | |||||||||
| 126600351 | 12660035 | 8 | C | FLUTICASONE PROPIONATE. | FLUTICASONE PROPIONATE | 1 | 50 ?G, 2X/DAY (BID), SPRAY | U | U | 0 | 50 | UG | BID | ||||||
| 126600351 | 12660035 | 9 | C | Acetaminophen w/hydrocodone | ACETAMINOPHENHYDROCODONE | 1 | 10/325 | U | U | 0 | |||||||||
| 126600351 | 12660035 | 10 | C | CELEBREX | CELECOXIB | 1 | Oral | 200 MG, ONCE DAILY (QD) | U | U | 0 | 200 | MG | CAPSULE | QD | ||||
| 126600351 | 12660035 | 11 | C | CELEBREX | CELECOXIB | 1 | U | U | 0 | CAPSULE | |||||||||
| 126600351 | 12660035 | 12 | C | CELEBREX | CELECOXIB | 1 | U | U | 0 | CAPSULE | |||||||||
| 126600351 | 12660035 | 13 | C | CELEBREX | CELECOXIB | 1 | U | U | 0 | CAPSULE | |||||||||
| 126600351 | 12660035 | 14 | C | LISINOPRIL. | LISINOPRIL | 1 | UNK | U | U | 0 | |||||||||
| 126600351 | 12660035 | 15 | C | LEFLUNOMIDE. | LEFLUNOMIDE | 1 | UNK | U | U | 0 | |||||||||
| 126600351 | 12660035 | 16 | C | METOPROLOL. | METOPROLOL | 1 | UNK | U | U | 0 | |||||||||
| 126600351 | 12660035 | 17 | C | MOBIC | MELOXICAM | 1 | 15 MG | U | U | 0 | |||||||||
| 126600351 | 12660035 | 18 | C | CLARITIN | LORATADINE | 1 | 10 MG ONE TWO TIMES A DAY | U | U | 0 | |||||||||
| 126600351 | 12660035 | 19 | C | CARBAMAZEPINE. | CARBAMAZEPINE | 1 | UNK | U | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126600351 | 12660035 | 1 | Product used for unknown indication |
| 126600351 | 12660035 | 2 | Product used for unknown indication |
| 126600351 | 12660035 | 3 | Product used for unknown indication |
| 126600351 | 12660035 | 4 | Product used for unknown indication |
| 126600351 | 12660035 | 5 | Product used for unknown indication |
| 126600351 | 12660035 | 6 | Product used for unknown indication |
| 126600351 | 12660035 | 7 | Gastric disorder |
| 126600351 | 12660035 | 8 | Product used for unknown indication |
| 126600351 | 12660035 | 9 | Product used for unknown indication |
| 126600351 | 12660035 | 10 | Rheumatoid arthritis |
| 126600351 | 12660035 | 11 | Fibromyalgia |
| 126600351 | 12660035 | 12 | Osteoporosis |
| 126600351 | 12660035 | 13 | Arthritis |
| 126600351 | 12660035 | 14 | Product used for unknown indication |
| 126600351 | 12660035 | 15 | Product used for unknown indication |
| 126600351 | 12660035 | 16 | Product used for unknown indication |
| 126600351 | 12660035 | 17 | Product used for unknown indication |
| 126600351 | 12660035 | 18 | Product used for unknown indication |
| 126600351 | 12660035 | 19 | Seizure |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126600351 | 12660035 | Headache | |
| 126600351 | 12660035 | Hypersensitivity |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 126600351 | 12660035 | 1 | 2015 | 2015 | 0 |